Hip and knee implant prices fell for more than a decade. When was the last time you renegotiated?
Strategic financial guidance for orthopedic groups managing implant costs, ASC decisions, partner economics, and growth opportunities.
A 4-minute test your accountant hopes you skip.
At a glance
TL;DR — What is a Orthopedics Fractional CFO?
A fractional CFO for orthopedic practices provides strategic financial leadership for orthopedic surgery groups — covering ASC ownership structures, implant vendor contract strategy, and physician compensation modeling — typically engaged by orthopedic owners with $3M–$25M in revenue managing capital-intensive growth decisions. Sorso is a fractional CFO firm that does this for orthopedic practices across the US, from $4,000 a month, month-to-month after onboarding, with a 45-day money-back guarantee.
Industry Context
The Strategic Picture for Orthopedic Practices
Orthopedics is one of the most heavily PE-consolidated specialties in healthcare. Platforms like U.S. Orthopaedic Partners (USOP), Healthcare Outcomes Performance Company (HOPCo), Spire Orthopedic Partners, and many regional players have rolled up groups, and FOCUS Investment Banking, an M&A adviser, puts 2026 orthopedic platform deals at 9x to 13x EBITDA. Practices with strong ASC participation, balanced subspecialty mix (joint, spine, sports, hand, foot/ankle, pediatric), and proven value-based contract performance get higher valuations.
The CFO conversations in orthopedics span equipment decisions (imaging, surgical equipment, robotic surgery systems), ASC strategy, payer contracting (especially around bundled payment programs), partner compensation methodology, and exit planning. Robotic-assisted surgery systems (Mako for joints, Mazor for spine) are capital decisions in the high six figures that affect surgical positioning, hospital relationships, and case volume. Bundled payment participation in CMS Comprehensive Care for Joint Replacement (CJR) and similar programs requires actuarial analysis and care pathway investment. A fractional CFO models these decisions and tracks the operational metrics that drive both current profitability and exit valuation.
Is This Right for You?
This service is for orthopedic practice owners facing these challenges:
Need accurate books first? Our Accounting service for orthopedic practices may be a better starting point.
Strategic Pitfalls
CFO-Level Mistakes We See in Orthopedic Practices
The strategic and capital-allocation errors that cost orthopedic practice owners the most.
01
Not negotiating implant prices annually
Implant manufacturers (Stryker, Zimmer Biomet, Smith & Nephew, DePuy, Globus) set prices contract by contract, so terms drift without active management. Practices that do not negotiate or rebid their contracts give up savings that would go straight to surgical margin; in a 2023 Journal of Arthroplasty review, hospital implant price-cap programs cut implant costs by 2.2% to 26.1%.
02
Buying robotic surgery systems without volume modeling
Mako, ROSA, and Mazor systems are major capital purchases: a 2022 study in the Journal of the American Academy of Orthopaedic Surgeons modeled buying and running a knee robot at $706,250 on average, plus a preoperative CT scan for each case. Without realistic case volume projections and a clear strategy for how the robot drives competitive positioning, the investment is hard to justify at low volume; in the same study, robot costs came to $71,025 per case at 10 knees a year and $3,931 at 200.
03
Inconsistent partner compensation across subspecialties
Joint surgeons, spine surgeons, sports medicine surgeons, and non-operative physicians have very different production profiles. Compensation models that treat them identically cause partner conflict and retention problems.
04
Underinvesting in physical therapy ancillary
Captive PT adds a revenue line and keeps post-op patients in the practice, which helps the surgical patient experience. Practices that underinvest in PT capacity miss the dual benefit of revenue and patient retention.
05
Selling to the first PE platform without competitive process
Orthopedic group valuations vary widely depending on which platform is bidding and how the deal is structured. Without a CFO to run a competitive process, owners have no way to know whether the first offer is the best one.
The Numbers That Matter
CFO Dashboard Metrics for Orthopedic Practices
Adjusted EBITDA
- Earnings before interest, taxes, depreciation, and amortization with owner compensation normalized.
Combined EBITDA Margin
- Adjusted EBITDA across practice and ASC as a percentage of combined collections.
ASC EBITDA Margin
What we look for: 35 percent or higher (Tenet's USPI ambulatory care segment reported $2,026M of adjusted EBITDA on $5,172M of revenue in 2025)
- ASC operating income divided by ASC collections.
Cost per Case
- Total surgical case cost (implant, supplies, professional, facility) by case type.
Bundled Payment Performance
- Actual cost vs target price under CJR or commercial bundled programs.
Subspecialty Revenue Mix
- Revenue by subspecialty as percentage of total.
Days Cash on Hand
- Cash reserves divided by average daily operating expenses.
Capital & Vendor Strategy
Equipment, Software, and Partner Decisions
Capital allocation in orthopedics is dominated by surgical and imaging equipment. Robotic surgery systems (Mako, ROSA, Mazor), which a 2022 JAAOS cost study modeled at $706,250 on average to buy and run, require multi-year volume justification. In-office MRI and CT systems require careful financial modeling against ancillary revenue projections. Surgical equipment vendors often bundle service contracts and consumable agreements that meaningfully affect total cost of ownership.
For practices considering exit, the work to maximize valuation includes documenting partner compensation methodology, building clean ASC financials, demonstrating value-based contract performance, and showing growth in high-value subspecialties. PE platforms look at specific subspecialty mix during diligence: joint replacement and spine drive premium multiples, sports medicine and hand are stable contributors, and non-operative orthopedics is less valued. Bundled payment partners (Remedy Partners, Signify Health, in-house programs) and value-based contract participants need clean cost-per-episode data that most practices do not have.
What's Included
How a Fractional CFO Works for Orthopedic Practices
Orthopedics-specific strategic leadership that goes beyond reporting.
ASC Strategy
- •ASC ownership valuation and optimization
- •Joint replacement outpatient migration planning
- •New surgeon recruitment financial modeling
- •Management company contract evaluation
Implant Cost Management
- •Vendor negotiation data preparation
- •Implant cost benchmarking by procedure type
- •Alternative implant evaluation and savings modeling
- •Implant cost pass-through vs bundled payment analysis
Partnership & Governance
- •Partner buyout valuation and restructuring
- •Compensation formula redesign
- •New partner buy-in pathway and timeline
- •Governance structure financial implications
Growth Planning
- •Subspecialty recruitment financial modeling
- •Satellite location feasibility
- •Service line expansion ROI (regenerative medicine, spine, sports medicine)
Results
Results in this example
| Metric | In this example |
|---|---|
| Implant cost savings | $150K–$200K range annually through vendor renegotiation and standardization |
| DME revenue recovered | Roughly $70K from billing process corrections |
| PT department improvement | Margin moved into the low teens through productivity changes, adding roughly $100K–$120K annually |
Illustrative Scenario
What This Looks Like In Practice
A multi-surgeon orthopedic group with ASC ownership, in-house PT, an imaging center, and DME dispensing, combined revenue in the $10M–$12M range. Partner take-home had slipped meaningfully over three years. Partners assumed the cause was reimbursement pressure, but most of the drift was operational.
What the review found:
- •Implant contracts had not been rebid in years; standardization and competitive bidding were worth an estimated $150K–$200K a year
- •The PT department running at a low-single-digit margin, driven by below-target visit productivity in several therapists
- •DME billed on a much smaller share of eligible visits than it was actually dispensed on, worth roughly $70K a year
- •Global surgery period coding errors leaving six figures a year uncollected on separately billable post-surgical services
Representative results
$150K–$200K range annually through vendor renegotiation and standardization
Implant cost savings
Roughly $70K from billing process corrections
DME revenue recovered
Margin moved into the low teens through productivity changes, adding roughly $100K–$120K annually
PT department improvement
The takeaway
The lesson from this example: the money usually is not stuck in the payer contracts. It is in implants, DME billing, and global-period coding, each of which gets lost in a blended P&L.
Think your orthopedic practice has similar potential?
Common Questions About Fractional CFO for Orthopedic Practices
How much does a fractional CFO for orthopedic practices cost?+
Fractional CFO starts at $4,000 a month, month-to-month after onboarding, with a 45-day money-back guarantee. It usually pays off from about $3M in revenue; below that, accounting from $2,000 a month is the better first step, and we will say so.
Do you also keep the books?+
If you want us to. Sorso's accounting service runs the monthly close, with implant cost per case and the practice, ASC and imaging entities, and the CFO work sits on top of it. If you already have a bookkeeper or controller, we work from their books. We are not a CPA firm, so tax filing stays with your CPA.
Do you work with orthopedic practices in my state?+
Yes. We work with orthopedic practices across the US. The work runs on your accounting, billing and payroll systems, so where the practice is does not change it.
How do you approach implant vendor negotiations?+
We prepare data: your current costs per procedure, competitive bids from alternative vendors, and volume commitments. Armed with data, you negotiate from strength instead of accepting annual price increases.
Should we move total joints to our ASC?+
We model the economics: facility fee capture, implant cost impact, staff and equipment requirements, and payer-specific reimbursement for outpatient total joint. CMS is pushing this direction and the margin opportunity is real — but the capital requirements are specific to your facility.
How do you value an orthopedic practice?+
We use adjusted EBITDA with orthopedic-specific multiples, separately valuing the practice, ASC, and ancillary operations. Practices with diverse ancillary revenue, multiple subspecialties, and ASC ownership earn higher multiples; FOCUS Investment Banking, an M&A adviser, puts 2026 orthopedic platform deals at 9x to 13x EBITDA and add-on deals at 6x to 9x.
How do you handle retiring partner buyouts?+
We value the departing partner's share using current valuation methodology (not a formula from 15 years ago), structure payment terms that the remaining partners can afford, and plan the operational transition to minimize revenue loss.
Should we add a regenerative medicine program?+
We model the economics: patient demand in your market, equipment and supply costs, marketing investment, and realistic revenue projections. Regenerative medicine can be high-margin but patient volume expectations from manufacturers are often inflated.
What is the biggest financial mistake in orthopedic practices?+
Not tracking implant costs at the case level. When you do not know your cost per case, you cannot negotiate effectively with vendors or make informed decisions about which procedures are worth your time.
Stop guessing. Start leading your orthopedic practice with data.
Take the 4-minute financial assessment—and find out if your orthopedic practice is ready for strategic CFO leadership.
Curious what you'd actually receive each month? See a sample monthly report →
Sources
Figures on this page come from these published sources. Rows marked Sorso estimate are our own arithmetic on them.
- CMS, Global Surgery booklet (MLN907166), December 2025
- CMS, 2026 Physician Fee Schedule relative value files
- Journal of Arthroplasty, 2026: implant prices and reimbursement in joint replacement, 2009-2021
- Journal of Arthroplasty, 2023: review of implant cost-containment programs
- Journal of the American Academy of Orthopaedic Surgeons, 2022: cost of robotic-assisted knee replacement
- California Labor Code section 4603.2 (workers comp payment deadlines)
- American Alliance of Orthopaedic Executives, benchmarking results for 2024
- American Academy of Family Physicians, practice finances and revenue cycle benchmarks
Other services for orthopedic practices
Orthopedic Practices Accounting
Healthcare-specialized bookkeeping and reporting for orthopedic practices.
Orthopedic Practices Revenue Cycle
RCM benchmarks and leak detection for orthopedic practices.
Medical practice bookkeeping
Medical practice bookkeeping: payer deposits matched to remittances, billing reconciled to the bank, books closed in 15 business days.
Medical practice accountant
A medical practice accountant for clinics and physician groups: monthly books, close and reporting.
By state
Orthopedic Practices accounting and CFO support, by state
State-level tax, payer, and regulatory context shapes what “good” looks like for orthopedic practices practices. The pages below walk through each state's specifics.